Simon Campbell

Last updated

Sir

Simon Campbell

Born
Simon Fraser Campbell

(1941-03-27) March 27, 1941 (age 82)
Lapal, England, United Kingdom
Alma mater University of Birmingham (BSc, PhD)
Awards
Scientific career
Institutions
Thesis Elimination processes in polyfluorocycloalkanes  (1966)

Sir Simon Fraser Campbell, CBE , FRS , FMedSci (born 27 March 1941) is a British chemist. [1]

Contents

Early life and education

Campbell was born on 27 March 1941 in Lapal, England. [3] He obtained a first-class BSc degree in Chemistry in 1962, a PhD degree in 1965, and an honorary DSc degree in 2004 from the University of Birmingham .

Career

He was President of the Royal Society of Chemistry from 2004 to 2006. [1] He led innovative research, discovering some of the world's best-selling prescription drugs, including sildenafil, amlodipine, and doxazosin. [4] He was visiting lecturer at Universidade de São Paulo.[ citation needed ] He was a medicinal chemist for Pfizer. [5] He was visiting professor at University of Leeds, and on the advisory board of University of Kent, and University of Bristol. [6]

Awards and honours

Campbell was knighted in the 2015 New Year Honours for services to chemistry, [7] [8] having previously been made a Commander of the Order of the British Empire (CBE).

Related Research Articles

Post-nominal letters, also called post-nominal initials, post-nominal titles, designatory letters or simply post-nominals, are letters placed after a person's name to indicate that the individual holds a position, an academic degree, accreditation, an office, a military decoration, or honour, or is a member of a religious institute or fraternity. An individual may use several different sets of post-nominal letters, but in some contexts it may be customary to limit the number of sets to one or just a few. The order in which post-nominals are listed after a name is based on rules of precedence and what is appropriate for a given situation. Post-nominal letters are one of the main types of name suffix. In contrast, pre-nominal letters precede the name rather than following it, such as addressing a physician or professor as "Dr. Smith".

<span class="mw-page-title-main">National Institute for Medical Research</span> Medical research institute in London, United Kingdom

The National Institute for Medical Research, was a medical research institute based in Mill Hill, on the outskirts of north London, England. It was funded by the Medical Research Council (MRC);

<span class="mw-page-title-main">Richard Henderson (biologist)</span> British biologist

Richard Henderson is a British molecular biologist and biophysicist and pioneer in the field of electron microscopy of biological molecules. Henderson shared the Nobel Prize in Chemistry in 2017 with Jacques Dubochet and Joachim Frank.„Thanks to his work, we can look at individual atoms of living nature, thanks to cryo-electron microscopes we can see details without destroying samples, and for this he won the Nobel Prize in Chemistry."

Steven Victor Ley is Professor of Organic Chemistry in the Department of Chemistry at the University of Cambridge, and is a Fellow of Trinity College, Cambridge. He was President of the Royal Society of Chemistry (2000–2002) and was made a CBE in January 2002, in the process. In 2011, he was included by The Times in the list of the "100 most important people in British science".

<span class="mw-page-title-main">Carol V. Robinson</span> British chemist and professor

Dame Carol Vivien Robinson, is a British chemist and former president of the Royal Society of Chemistry (2018–2020). She was a Royal Society Research Professor and is the Dr Lee's Professor of Physical and Theoretical Chemistry, and a professorial fellow at Exeter College, University of Oxford. She is the first director of the Kavli Institution for Nanoscience Discovery, University of Oxford, and she was previously professor of mass spectrometry at the chemistry department of the University of Cambridge.

Mariann Bienz, Lady Pelham FRS FMedSci is a Swiss-British molecular biologist based at the UK Medical Research Council Laboratory of Molecular Biology. She has been a member of their Senior Scientific Staff since 1991, was Joint-head of Cell Biology in 2007-08 and has been a Group Leader of Protein and Nucleic Acid Chemistry Division since 2008.

<span class="mw-page-title-main">Tomas Lindahl</span> Swedish-British scientist

Tomas Robert Lindahl FRS FMedSci is a Swedish-British scientist specialising in cancer research. In 2015, he was awarded the Nobel Prize in Chemistry jointly with American chemist Paul L. Modrich and Turkish chemist Aziz Sancar for mechanistic studies of DNA repair.

<span class="mw-page-title-main">Harren Jhoti</span>

Harren Jhoti is an Indian-born British structural biologist whose main interest has been rational drug design and discovery. He is president and chief executive officer (CEO) of biotechnology company Astex Pharmaceuticals ("Astex") which is located in Cambridge, United Kingdom.

Martin Bobrow is a British geneticist, and Emeritus Fellow, Wolfson College, Cambridge.

Doreen Ann CantrellCBE, FRS, FRSE, FMedSci is a Scottish scientist and Professor of Cellular Immunology at the School of Life Sciences, University of Dundee. She researches the development and activation T lymphocytes, which are key to the understanding the immune response.

Dame Anne Jane Mills, is a British authority on health economics. She is deputy director and Provost and Professor of Health Economics and Policy at the London School of Hygiene and Tropical Medicine.

<span class="mw-page-title-main">Dai Rees (biochemist)</span> British biochemist (1936–2021)

Sir David Allan "Dai" Rees, FRS was a British biochemist and science administrator who was chief executive of the Medical Research Council between 1987 and 1996.

<span class="mw-page-title-main">Richard Perham</span>

Richard Nelson Perham, FRS, FMedSci, FRSA, was Professor of biochemistry at the University of Cambridge, and Master of St John's College, Cambridge 2004–07. He was also editor-in-chief of FEBS Journal from 1998 to 2013.

<span class="mw-page-title-main">Trevor M. Jones</span>

Trevor Mervyn Jones, CBE PhD DSc (Hon) FRCP FMedSci FBPhS FRSM FRSC FLSW is a visiting professor at King's College London, and a former Head of R&D, at Wellcome. He continues to have a distinguished career in the pharmaceutical and biotech industry as well as in academia.

<span class="mw-page-title-main">Wendy Bickmore</span> British genome biologist (born 1961)

Wendy Anne Bickmore is a British genome biologist known for her research on the organisation of genomic material in cells.

<span class="mw-page-title-main">Jack Cuzick</span> American-British epidemiologist (born 1948)

Jack Martin Cuzick is an American-born British academic, director of the Wolfson Institute of Preventive Medicine in London and head of the Centre for Cancer Prevention. He is the John Snow Professor of Epidemiology at the Wolfson Institute, Queen Mary University of London.

Sir David Klenerman is a British biophysical chemist and a professor of biophysical chemistry at the Department of Chemistry at the University of Cambridge and a Fellow of Christ's College, Cambridge.

<span class="mw-page-title-main">David Rees (organic chemist)</span> British chemist

David Charles Rees CChem FRSC FMedSci is a chemist recognised internationally for his innovative use of chemistry in drug discovery. He is Chief Scientific Officer of biotechnology company Astex Pharmaceuticals, which is located in Cambridge, UK.

<span class="mw-page-title-main">Fiona Marshall (pharmacologist)</span> British pharmacologist

Fiona Hamilton Marshall is a British pharmacologist, founder and Senior Vice President of Discovery, Preclinical & Translational Medicine at Merck & Co. She will become the next president of the Novartis Institutes for BioMedical Research. She previously served as Chief Scientific Officer at Heptares Therapeutic, where she was Vice President of the Japanese biopharmaceutical company Sosei. She was elected Fellow of the Academy of Medical Sciences in 2016 and the Royal Society in 2021.

References

  1. 1 2 3 Campbell, S (2006). "Simon Campbell CBE, FMed Sci, FRS. Interview by Joanna Owens". Nature Reviews Drug Discovery. 5 (8): 626. doi: 10.1038/nrd2116 . PMID   16918018. S2CID   38734548.
  2. "SIMON FRASER CAMPBELL (Director) :: OpenCorporates". Archived from the original on 1 January 2015. Retrieved 1 January 2015.
  3. "Dr Simon Campbell receives CBE at Buckingham Palace". Royal Society of Chemistry. 14 December 2006. Retrieved 14 January 2023.
  4. "Scientist who developed Viagra receives knighthood in New Year's Honours". The Pharmaceutical Journal. Royal Pharmaceutical Society. 2014. doi:10.1211/pj.2014.20067494. ISSN   2053-6186.
  5. Simon Campbell C.B.E F.R.S Ph.D. "Astex Therapeutics Limited: Private Company Information - BusinessWeek". Investing.businessweek.com. Retrieved 1 December 2011.[ dead link ]
  6. "Dr Simon Campbell, CBE, FRS, FMedSci Authorised Biography – Debrett's People of Today, Dr Simon Campbell, CBE, FRS, FMedSci Profile". Debretts.com. 27 March 1941. Archived from the original on 28 July 2012. Retrieved 1 December 2011.
  7. "No. 61092". The London Gazette (Supplement). 31 December 2014. p. N2.
  8. 2015 New Year Honours List